Ispecimen Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Ispecimen Inc 's ROA in the second quarter of 2026?
Ispecimen Inc recorded a cumulative net loss of $-11 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -140.36%.

However, within the Healthcare sector 798 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4386, from total ROA ranking in the first quarter of 2026 at 5050.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	22.72 %	-3.41 %	-58.48 %	-20.12 %	-49.3 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-11	-11	-10	-12	-10
Return On Assets (TTM)	-140.36 %	-142.49 %	-133.57 %	-102.9 %	-86.56 %
ISPC's Total Ranking	# 4386	# 5050	# 4510	# 4524	# 4581
Total Assets (TTM) in million	7	7	10	9	6
Seq. Total Assets Change	12.04 %	-30.65 %	5.93 %	49.1 %	-11.82 %
Seq. Net Income Change	-	-	-	-	-

ISPC's 5 Years Annual ROA >> Back to ISPC Management Effectiveness >> Compare ISPC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 35
Sector	# 799
Overall	# 4339

Return On Assets Statistics
High	Average	Low
-27.8 %	-79.04 %	-147.74 %
(Mar 31 2022)		(Sep 30 2025)

News about Ispecimen inc Return on Assets ROA

iSpecimen Inc Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and Stability

iSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and StabilityiSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and StabilityIn a significant development for investors and stakeholders alike, iSpecimen Inc. (Nasdaq: ISPC) has successfully closed a public offering amounting to approximately $5 million. This investment marks a pivotal moment for the Woburn, Massachusetts-based company, which operates a global online marketplace connecting scientists with healthcare specimen providers for biospecimen procurement.On October 31, 2024, iSpecimen announced that the offering included common stock and pre-funded warrants priced at $3.00 per share, with a minuscule adjustment for the pre-funded warrants of $0.0001. The company has earmarked proceeds from this offering primarily for the repayment of outstanding debt, along with potential acquisitions aimed at augmenting its business capabilities. This move underscores iSpecimen s commitment to pursuing strategic growth through investments in essential assets, technologies, and enhanced marketing initiatives. Remaining proceeds will be allocated for working capital, thus providing increased operational flexibility.

Financial Statements
Ispecimen Inc 's Assets	$ 7 million	ISPC's Balance sheet
Ispecimen Inc 's Income	$ -1 million	Quarterly ISPC's Income Statement
ISPC's Income by Division		See ISPC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-58.48 %	45.13 %	-35.74 %	-31.08 %	-
Total Assets in million	10	23	16	25	36
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-10	-12	-11	-10	-9
Annual Return On Assets	-110.03 %	-54.44 %	-70.16 %	-41.62 %	-25.09 %

ISPC's 5 Years Annual ROA >> Back to ISPC Management Effectiveness >> Compare ISPC ROA to its Competitors

More Return On Assets Ratios
ISPC's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ISPC's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ISPC's Competitors
Subscribers only: Roa for Ispecimen Inc 's Suppliers
Subscribers only: Return On Assets for ISPC's Customers

You may also want to know
ISPC's Roi	ISPC's Inventory Turnover Ratio	ISPC's Growth Rates	ISPC's Dividend Comparisons
	ISPC's Profitability Ratios	ISPC's Asset Turnover Ratio	ISPC's Dividend Growth
ISPC's Roe	ISPC's Valuation Ratios	ISPC's Financial Strength Ratios	ISPC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:40:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.